Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023

Rhea-AI Summary

Organogenesis Holdings Inc. (Nasdaq: ORGO), a key player in regenerative medicine, will release its first quarter 2023 financial results on May 10th after market close. The company specializes in advanced wound care and surgical and sports medicine solutions. Following the release, management will hold a conference call at 5:00 PM ET to discuss financial results and provide a corporate update. Interested parties can access the live webcast or telephone call through provided links. The archived version will be available on the company’s investor website for one year.

CANTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that first quarter of fiscal year 2023 financial results will be reported after the market closes on Wednesday, May 10th.

Management will host a conference call at 5:00 p.m. Eastern Time on May 10th to discuss the results of the quarter and provide a corporate update with a question and answer session. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.organogenesis.com. The webcast will be archived on the company website for approximately one year.

About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care.

FAQ

When will Organogenesis report its Q1 2023 financial results?

Organogenesis will report its first quarter 2023 financial results after the market closes on May 10th.

What time is the conference call for Q1 2023 results?

The conference call to discuss the Q1 2023 results will take place at 5:00 PM ET on May 10th.

How can I access the Q1 2023 results conference call?

You can access the conference call via a live webcast or teleconference through links provided in the press release.

Where can I find the archived Q1 2023 results webcast?

The archived webcast will be available on Organogenesis' investor website for approximately one year.